CN1243569C - 活性p40结合物在鼻腔途径给药中的应用 - Google Patents

活性p40结合物在鼻腔途径给药中的应用 Download PDF

Info

Publication number
CN1243569C
CN1243569C CNB998062650A CN99806265A CN1243569C CN 1243569 C CN1243569 C CN 1243569C CN B998062650 A CNB998062650 A CN B998062650A CN 99806265 A CN99806265 A CN 99806265A CN 1243569 C CN1243569 C CN 1243569C
Authority
CN
China
Prior art keywords
aaa
pro
lys
asn
aac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998062650A
Other languages
English (en)
Chinese (zh)
Other versions
CN1301176A (zh
Inventor
C·安德瑞珀尼
I·雷尤利
T·恩盖恩
J－F·亨尤
T·保斯安特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of CN1301176A publication Critical patent/CN1301176A/zh
Application granted granted Critical
Publication of CN1243569C publication Critical patent/CN1243569C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CNB998062650A 1998-03-27 1999-03-26 活性p40结合物在鼻腔途径给药中的应用 Expired - Fee Related CN1243569C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803814A FR2776521B1 (fr) 1998-03-27 1998-03-27 Utilisation de conjugues p40 actifs par voie nasale
FR98/03814 1998-03-27

Publications (2)

Publication Number Publication Date
CN1301176A CN1301176A (zh) 2001-06-27
CN1243569C true CN1243569C (zh) 2006-03-01

Family

ID=9524572

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998062650A Expired - Fee Related CN1243569C (zh) 1998-03-27 1999-03-26 活性p40结合物在鼻腔途径给药中的应用

Country Status (8)

Country Link
EP (1) EP1066054A2 (fr)
JP (1) JP2002509897A (fr)
CN (1) CN1243569C (fr)
AU (1) AU764061B2 (fr)
BR (1) BR9909180A (fr)
CA (1) CA2324477A1 (fr)
FR (1) FR2776521B1 (fr)
WO (1) WO1999049892A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798857B1 (fr) * 1999-09-23 2003-06-06 Pf Medicament Utilisation d'une proteine de membrane ompa d'enterobacterie associee a un peptide immunogene du vrs pour la preparation de vaccins administrables par voie nasale
FR2805163A1 (fr) * 2000-02-21 2001-08-24 Pf Medicament Utilisation d'un detergent de type zwittergent pour la preparation d'une composition pharmaceutique destinee a etre administree par voie nasale
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
CN1549726A (zh) * 2000-07-31 2004-11-24 耶鲁大学 先天性免疫系统指导的疫苗
FR2827605B1 (fr) 2001-07-20 2004-07-16 Pf Medicament Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
FR2828106A1 (fr) * 2001-08-02 2003-02-07 Pf Medicament Utilisation d'une omp d'enterobacterie de faible masse moleculaire comme porteur et/ou adjuvant
CN112062820B (zh) * 2020-08-24 2023-05-26 黑龙江八一农垦大学 大肠杆菌重组外膜蛋白a包涵体蛋白的复性纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
FR2718452B1 (fr) * 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
FR2726472B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
FR2748476B1 (fr) * 1996-05-07 1998-08-14 Pf Medicament Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant

Also Published As

Publication number Publication date
WO1999049892A2 (fr) 1999-10-07
AU764061B2 (en) 2003-08-07
EP1066054A2 (fr) 2001-01-10
CA2324477A1 (fr) 1999-10-07
FR2776521A1 (fr) 1999-10-01
WO1999049892A3 (fr) 2000-03-30
JP2002509897A (ja) 2002-04-02
AU2939199A (en) 1999-10-18
BR9909180A (pt) 2000-12-05
FR2776521B1 (fr) 2000-12-15
CN1301176A (zh) 2001-06-27

Similar Documents

Publication Publication Date Title
CN1179973C (zh) 含有通过肽配体连接的多个免疫原性成分的hbv核心抗原颗粒
CN1188519C (zh) 包含HIV－1Tat和/或Nef蛋白的融合蛋白
CN100339482C (zh) 奈瑟球菌蛋白质的杂交表达
CN1246038C (zh) 全身性送递肉毒杆菌毒素口服疫苗
CN1201818C (zh) 疫苗
CN1282656C (zh) 来自gagp17和p24保守区域的HIV肽以及它们在例如疫苗中的应用
CN1556857A (zh) 呼吸道合胞病毒(rsv)g蛋白的新肽及其在疫苗中的应用
CN1659187A (zh) 融合铁蛋白在疫苗和其他方面的应用
CN1209437A (zh) 获得具有正确键合的胱氨酸键的胰岛素前体的改进的方法
CN1217724A (zh) 降钙素片段的重组制备方法和其在制备降钙素和相关类似物中的用途
CN1798844A (zh) Sars病毒抗原的细胞表面表达载体和用该载体转化的微生物
CN1203173C (zh) 转谷氨酰胺酶的制备方法
CN1243569C (zh) 活性p40结合物在鼻腔途径给药中的应用
CN1198918C (zh) 减毒的活胸膜肺炎放线杆菌
CN1718243A (zh) 一类免疫佐剂及其在抗病毒疫苗或药物制备中的应用
CN1245512C (zh) 含重组菌毛蛋白的抗淋病奈瑟氏球茵或脑膜炎奈瑟氏球菌的疫苗
CN1849334A (zh) 胞内劳森氏菌亚单位疫苗
CN1314806C (zh) 小型化抗eb病毒肿瘤多肽及其应用与制备方法
CN1274829C (zh) 抗eb病毒所致肿瘤多肽及其应用与制备方法
CN1899610A (zh) 幽门螺杆菌抗原重组疫苗
CN1046559A (zh) 制备胰高血糖素的方法
CN1545552A (zh) 基因和蛋白质及它们的用途
CN1496370A (zh) 分离的苛养木杆菌gum操纵子,分离的其核酸分子及它们的用途
CN1218749C (zh) 预防动物口蹄疫病毒的感染的重组蛋白疫苗及其用途
CN100338091C (zh) 编码新的融合蛋白的dna和通过该dna的表达来制备有用的多肽的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee